Introduction
Clinical laboratories are under constant pressure to provide a high-quality service, improve efficiency and keep costs to a minimum so they need 
Intra-assay imprecision
All thyroid assays were very precise, with intra-assay CVs ranging from 1"9 to 4"8%, verifying the assay specifications given by the manufacturer of _<5"5% for TSH and _<6"0% for FT4.
The intra-assay imprecision was between 1"8 and 4"9% for the tumour marker assays for all sample materials used. Only PSA gave a CV of 6"4% at a very low concentration of 0"6 ng/ml, far from the cut-off value of 4 ng/ml. All CVs, except for the low level serum pool for PSA, were within the limits (<5%) given in Quality Control and Standardization of Tumour Marker Tests [6] .
Inter-assay imprecision
CVs for the TSH assay ranged from 2" 1% to 4"2%. No value exceeded the acceptance limits of 10-15% set by the American Thyroid Association [7] and the specifications of Roche Diagnostics of <_6"5%. The imprecision for FT4 was less than 5"7% for the low and medium conrol sera and for the human serum pool. The CV for the high control sera was 8"5% and therefore outside the manufacturer's specification of <_8%. However, the concentration level of these samples (72"3 pmol/1) was outside the clinical decision range.
The CVs for T3 ranged from 2"1 to 7"7%, and were therefore all within the manufacturer's specification (<_8%). In addition, the imprecision for the selected thyroid panel showed good correspondence to results found in a recently published thyroid study [13] , although a better imprecision for T3 in the high measuring range was obtained.
Inter-assay CVs for all tumour markers tested ranged from 2"0 to 7"8%, therefore they met the specifications for the inter-assay imprecision of <5-8%, suggested observed on the second day with the automatic dilution 1:100, for which no explanation could be given.
The inter-assay CV for a human serum pool (CEA concentration 96 ng/ml) and for a Lyphochek Control Serum (AFP concentration 252 ng/ml) both automatically diluted to 1:10 by the COBAS Core I I system. An inter-run variation of 7"6% was observed for CEA, a CV of 3"2% was observed for AFP. This is within the range of CVs found with undiluted samples for the COBAS Core CEA assay (see table 3 [a]). II  III  II  III  II  III  II  III Control1 CEA (ng/mL) PSA (ng/mL) AFP (ng/mL) 6-HCG CA (mlU/mL) (U/mL) Figure 1 . 
Method Comparison

